Atlas Brown’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Atlas Brown’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-405	Closed	-$4K	–	192
2022 Q1	$4K	Buy	405 +1	+0.2%	+$15	﹤0.01%	187
2021 Q4	$9K	Hold	404	–	–	﹤0.01%	194
2021 Q3	$13K	Buy	+404	New	+$14.8K	0.01%	180

Other funds holding SRGA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Atlas Brown's SRGA Position: Q2 2022 in Review

Atlas Brown sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2022, closing a stake of 405 shares — an estimated $4K sold.

Atlas Brown first reported a position in SRGA in Q3 2021 and held it in 3 quarters. The position peaked at $13K in Q3 2021. 40 funds tracked by Wall St. Rank hold SRGA as of Q2 2022.

Atlas Brown reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Atlas Brown sold 405 Surgalign Holdings, Inc. Common Stock shares in Q2 2022, an estimated $4K.
Atlas Brown first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
Atlas Brown's Surgalign Holdings, Inc. Common Stock position peaked at $13K in Q3 2021.
40 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2022.

Based on Atlas Brown's 13F filing for Q2 2022, filed 15 Jul 2022.